DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Exelixis (NASDAQ: EXEL)

1.33 -0.02 (-1.48%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

EXEL $1.33 -1.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.39
Previous Close $1.35
Daily Range $1.32 - $1.42
52-Week Range $1.28 - $8.41
Market Cap $259.6M
P/E Ratio -0.92
Dividend (Yield) $0.00 (0.0%)
Volume 12,186,749
Average Daily Volume 2,213,712
Current FY EPS -$1.41

Sector

Healthcare

Industry

Drugs

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website: http://www.exelixis.com/

News & Commentary Rss Feed

3 Healthcare Stocks to Watch in 2015

These are the three healthcare stocks you need to be watching heading into next year.

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results -

Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog

Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog

Exelixis' Partners File New Drug Application For Cobemetinib - Welcome News But Little Impact

Array BioPharma Advances To All Systems Go, Collects $85 Million

Exelixis' COMET-2 Failure And A Discussion Of Potential Future Cash Flow

Exelixis Shares Down on COMET-2 Study Results on Cabozantinib - Analyst Blog

Is Exelixis, Inc. Stock Doomed?

Small-cap biotech Exelixis has fallen hard in 2014. Could the stock rebound next year, or will it drop even further?

Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

See More EXEL News...

EXEL's Top Competitors

EXEL $1.33 (-1.48%)
Current stock: EXEL
TMO $128.45 (0.73%)
Current stock: TMO
ILMN $189.97 (1.43%)
Current stock: ILMN
WAT $115.09 (0.73%)
Current stock: WAT